Stock Watch

JPMorgan Chase Tops Expectations With Second-Quarter Results

JPMorgan Chase Tops Expectations With Second-Quarter Results

JPMorgan Chase (JPM) reported second-quarter results that came in ahead of Wall Street’s expectations, with its chief executive offering upbeat comments about US consumers even as geopolitical uncertainty hindered the markets segment and the bank lowered its view for full-year net interest income. Earnings increased to $2.82 a share from $2.65 in the same period of 2018, ahead of the […]

AxoGen to Expand Enrollment of Phase 3 Study of Avance Nerve Graft

AxoGen to Expand Enrollment of Phase 3 Study of Avance Nerve Graft

AxoGen (AXGN) said Monday that it has completed the planned interim analysis for its phase 3 RECON study, which will support the submission of a Biologic License Application (BLA) to the Food and Drug Administration for for its Avance Nerve Graft. Based on the results of the interim analysis, the study’s independent biostatistician recommended continuation of the study with a […]